|
Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.8990 EUR | +0.90% |
|
-5.37% | -23.68% |
| 06-01 | NFL Biosciences Releases New Results on NFL-101 and Reaffirms Its Personalized Approach to Smoking Cessation | CI |
| 06-01 | NFL Biosciences validates breakthrough in personalized medicine |  |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Bio Therapeutic Drugs
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 13.01M | - | - | - | - | - |
| 55.58B | |||||
| 43.47B | |||||
| 22.64B | - | ||||
| 20.96B | - | ||||
| 15.79B |
- Stock Market
- Stocks
- ALNFL Stock
- Charts NFL Biosciences
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
